- This event has passed.
A Step Forward: Development of Effective Allogeneic CAR-T Strategies
September 16 @ 9:00 am - 10:30 am UTC-7
Can our bodies be trained to destroy cancer cells? CAR-T therapies have undoubtedly garnered significant attention and investment over the past several years even with the risks and development challenges that scientists continue to face. In the BioHealth Capital Region, gene therapy companies are rapidly emerging making the District of Columbia and its’ surrounding area a new hub for gene therapy. Through external partnership, Janssen R&D is jointly working to develop solutions in the gene therapy and CAR-T space.
The bewildering pace of change in this field poses challenges for regulators and providers in selecting the right CAR-T products for the right patients at the right time. Johnson & Johnson Innovation, JLABS has gathered thought leaders and innovators in the field to share the exciting research and technologies they are advancing and insights on what the future could look like for the area of immuno-oncology.